BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,124 filers reported holding BAXTER INTL INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $452,201 | -11.5% | 11,982 | +6.8% | 0.03% | -12.1% |
| Q2 2023 | $511,047 | +13.6% | 11,217 | +1.1% | 0.03% | +6.5% |
| Q1 2023 | $449,973 | +10.1% | 11,094 | +38.4% | 0.03% | -3.1% |
| Q4 2022 | $408,626 | -2.0% | 8,017 | +3.5% | 0.03% | -8.6% |
| Q3 2022 | $417,000 | 0.0% | 7,749 | +19.3% | 0.04% | -5.4% |
| Q2 2022 | $417,000 | -12.4% | 6,496 | +5.8% | 0.04% | -2.6% |
| Q1 2022 | $476,000 | +25.9% | 6,140 | +39.3% | 0.04% | +26.7% |
| Q4 2021 | $378,000 | +10.5% | 4,409 | +3.6% | 0.03% | 0.0% |
| Q3 2021 | $342,000 | +14.0% | 4,254 | +14.2% | 0.03% | +11.1% |
| Q2 2021 | $300,000 | -4.5% | 3,725 | -0.0% | 0.03% | -15.6% |
| Q1 2021 | $314,000 | +18.0% | 3,726 | +12.0% | 0.03% | +10.3% |
| Q4 2020 | $266,000 | +16.2% | 3,326 | +16.8% | 0.03% | 0.0% |
| Q3 2020 | $229,000 | +3.6% | 2,847 | +11.1% | 0.03% | -6.5% |
| Q2 2020 | $221,000 | -57.4% | 2,563 | -59.9% | 0.03% | -67.7% |
| Q1 2019 | $519,000 | +27.5% | 6,384 | +3.3% | 0.10% | +17.1% |
| Q4 2018 | $407,000 | -27.7% | 6,180 | -15.4% | 0.08% | -17.2% |
| Q3 2018 | $563,000 | -32.5% | 7,309 | -35.3% | 0.10% | -35.3% |
| Q2 2018 | $834,000 | -33.5% | 11,294 | -41.5% | 0.15% | -30.8% |
| Q1 2018 | $1,255,000 | -30.3% | 19,290 | -30.8% | 0.22% | -18.8% |
| Q4 2017 | $1,801,000 | -51.4% | 27,864 | -52.8% | 0.27% | -51.3% |
| Q3 2017 | $3,708,000 | -6.9% | 59,095 | -10.2% | 0.56% | -2.4% |
| Q2 2017 | $3,984,000 | +14.0% | 65,802 | -2.4% | 0.57% | +24.6% |
| Q1 2017 | $3,495,000 | +688.9% | 67,388 | +575.0% | 0.46% | +800.0% |
| Q4 2016 | $443,000 | -31.0% | 9,984 | -26.0% | 0.05% | -27.1% |
| Q3 2016 | $642,000 | -11.9% | 13,485 | -16.4% | 0.07% | -6.7% |
| Q2 2016 | $729,000 | +4.6% | 16,123 | -5.0% | 0.08% | +7.1% |
| Q1 2016 | $697,000 | +14.1% | 16,978 | +6.0% | 0.07% | +2.9% |
| Q4 2015 | $611,000 | +16.2% | 16,024 | 0.0% | 0.07% | +23.6% |
| Q3 2015 | $526,000 | -44.2% | 16,024 | +18.9% | 0.06% | -40.9% |
| Q2 2015 | $943,000 | -2.9% | 13,481 | -4.9% | 0.09% | +3.3% |
| Q1 2015 | $971,000 | -30.9% | 14,177 | -26.1% | 0.09% | -26.2% |
| Q4 2014 | $1,406,000 | -28.8% | 19,184 | -30.3% | 0.12% | -14.7% |
| Q3 2014 | $1,975,000 | -8.6% | 27,515 | -8.0% | 0.14% | -2.7% |
| Q2 2014 | $2,162,000 | -10.7% | 29,903 | -9.1% | 0.15% | -5.8% |
| Q1 2014 | $2,420,000 | -1.3% | 32,889 | -6.7% | 0.16% | +2.6% |
| Q4 2013 | $2,452,000 | -6.4% | 35,250 | -11.6% | 0.15% | -9.0% |
| Q3 2013 | $2,619,000 | -12.6% | 39,865 | -7.8% | 0.17% | -12.1% |
| Q2 2013 | $2,995,000 | – | 43,232 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |